Risk factors
|
HR
|
95% CI
|
p valuea
|
---|
Age
| | | |
≤70 y
|
1
|
Reference
| |
>70 y
|
2.29
|
0.87–6.72
|
0.095
|
ECOG PS
| | | |
0
|
1
|
Reference
| |
1
|
1.33
|
0.47–3.53
|
0.59
|
Tumor diameter
| | | |
≤30 mm
|
1
|
Reference
| |
>30 mm
|
3.47
|
1.35–8.98
|
0.010
|
VPI
| | | |
Absent
|
1
|
Reference
| |
Present
|
3.18
|
1.11–8.84
|
0.032
|
ALI
| | | |
Absent
|
1
|
Reference
| |
Present
|
1.06
|
0.38–3.15
|
0.91
|
Differentiation
| | | |
Well
|
1
|
Reference
| |
Moderate/Poor
|
1.14
|
0.42–3.01
|
0.80
|
Serum CEA
| | | |
NN group
|
1
|
Reference
| |
HN group
|
2.52
|
0.72–8.11
|
0.14
|
HH group
|
7.69
|
2.46–23.7
|
< 0.001
|
-
OS, Overall survival; HR, Hazard ratio; CI, Confidence interval; ECOG PS, European cooperative oncology group performance status; VPI, Visceral pleural invasion; ALI, Angiolymphatic invasion; CEA, Carcinoembryonic antigen.
-
a the log-rank test.